Singapore | Financials

Asia Pacific Equity Research

UOB | BUY MARKET CAP: USD 29B

10 Sep 2014 Company Update

AVG DAILY TURNOVER: USD 34M

UPGRADING TO BUY

BUY (upgrade)

  

Fair value

S$25.00

add: 12m dividend forecast

S$0.600

versus: Current price

S$22.90

Still a good Asian franchise Slow and steady growth strategy Upgrade to BUY, FV of S$25.00

12m total return forecast

Deepening its intra-Asian roots Continuing with its focus of tapping on rising intra-regional trades, UOB recently shared more details of this strategy at its Corporate Day; this by leveraging on the potential for further trade flows within the region including further cooperation within the ASEAN Economic Community (AEC).

12%

Analysts Carmen Lee (Lead) ● +65 6531 9802 [email protected] Carey Wong ● +65 6531 9808 [email protected] Key information Market cap. (m)

UOB Malaysia – still a key market, but cost could move higher Going forward, with the investment in infrastructure investments, management expects the cost-to-income ratio to move up from prevailing low rates of 34.1%-37.2% (FY09-13) in Malaysia, which is lower than at the group’s level (41.8% as of 2Q14). Corporate/Business banking will remain key; as there is still a sizeable pool of companies in Malaysia and the economy is still growing at a healthy rate. OCBC Treasury Market Research & Strategy is projecting GDP growth of 5.3% for 2014, up from 4.7% in 2013. For the Malaysian economy, we believe growth will be supported by exports recovery and a healthy and stable financial market. Outbound trades from Malaysia have also been growing, and there has been a recent improvement in non-commodity exports. UOB Malaysia generated average ROE of 17.5% from 2001-2013, and is ranked 7th in terms of gross loans (>5% market share) in Malaysia. It posted net profit of RM1342m in FY13 and this accounted for 15% to UOB Group’s PBT in FY13 – the largest of its overseas operations. In terms of 5-yr CAGR, PBT stood at 18% and total assets was 20%. NPLs were manageable at 1.7% (gross). We also like its FDI Advisory framework, which has a long term effect of further entrenching its clients for more banking services and business flows. Medium term re-rating likely; upgrade to BUY Post its recent results, the stock fell from the recent high of S$24.24 to a recent low of S$22.53. We are seeing value emerge again in the stock, especially with the more optimistic outlook and the recent rerating of banking stocks in the region. Based on comparables’ average Price/Book of 1.4x, we are raising our valuation from S$23.87 to S$25.00. Together with a 3% dividend yield and a potential total return of 12%, we are upgrading the stock to a BUY. FY12

FY13

FY14F

FY15F

Interest Income

6,202

6,508

7,100

7,406

Interest Expense

2,285

2,388

2,582

2,702

Non-interest Income

2,578

2,601

2,846

3,074

Net profits

2,803

3,009

3,040

3,263

1.8

1.9

1.9

2.0

na

na

1.9

2.0

Non-interest income growth (%)

27.6

0.9

9.4

8.0

Interest Inc / Total Inc (%)

60.3

61.3

61.4

60.5

EPS (S$) Cons. EPS (S$)

Dividend yield (%) PER (x)

Avg daily turnover (m)

S$43 / USD34

Avg daily vol. (m)

2.0

52-wk range (S$)

19.3552 - 24.24

Free float (%)

93.2

Shares o/s. (m)

1,601.3

Exchange

SGX

BBRG ticker

UOB SP

Reuters ticker

UOBH.SI

ISIN code

U11

GICS Sector

Financials

GICS Industry Top shareholder Relative total return

Financials Wee Inv - 7.6% 1m

3m

12m

Company (%)

2

2

16

STI-adjusted (%)

-1

0

4

Price performance chart

Sources: Bloomberg, OIR estimates

Industry-relative metrics

Key financial highlights Year ended 31 Dec (S$m)

S$36,846 / USD29,194

3.0

3.3

3.3

3.3

13.2

12.3

12.1

11.3

Please refer to important disclosures at the back of this document.

Note: Industry universe defined as companies under identical GICS classification listed on the same exchange. Sources: Bloomberg, OIR estimates

HOLD (maintain) MCI (P) 004/06/2014

OCBC Investment Research Singapore Equities

Exhibit 1: Comparison of 2Q14 financials In S$m

OCBC 2Q14

OCBC 2Q13

OCBC 1Q14

DBS 2Q14

DBS 2Q13

DBS 1Q14

UOB 2Q14

UOB 2Q13

UOB 1Q14

348,414 175,572 201,297 87.2%

313,225 157,172 176,265 89.2%

343,638 173,456 199,403 87.0%

417,275 257,355 299,399 86.0%

386,600 234,787 274,608 85.5%

418,979 253,229 301,490 84.0%

296,983 189,695 216,128 87.8%

274,000 169,909 199,273 85.3%

295,999 185,270 216,617 85.5%

Stockbroking / Futures Investment related Trade & remittances Loan-related Deposit-related / Services Credit card Fund management Wealth management Others Fee & Commission

12 25 58 69 17 18 27 114 13 353

18 24 51 73 20 17 26 109 9 347

14 16 53 74 21 16 25 116 18 353

42 52 131 93

57 47 137 94

43 43 140 118

88

82

83

97 69 99 26 71 38

112 68 103 26 66 43

114 66 101 27 62 32

138 17 561

101 17 535

117 23 567

11 411

17 435

12 414

Fee & commission Dividend Rental income Other income Insurance - Net trading income - Net income fr inv securities Non-interest Income

353 56 18 164 259

347 37 17 149 56

353 11 17 196 223

503

477

510

15

69

251

410 27 30 293

436 29 29 133

414 4 29 195

850

606

800

176 62 756

336 45 927

362 38 1,161

760

627

642

Int Income Int Expense Net Interest Income Non-interest Income Total Income Total operating expenses Operating profits Allowances for credit & other losses Pretax profits Net profits

1,776 650 1,126 850 1,976 760 1,216

1,524 563 961 606 1,567 718 849

1,707 620 1,087 800 1,887 706 1,181

2,218 661 1,557 756 2,313 1,054 1,259

1,975 593 1,382 927 2,309 711 1,598

2,129 641 1,488 1,161 2,649 1,041 1,608

1,761 637 1,124 760 1,884 787 1,097

1,606 591 1,015 627 1,642 726 916

1,745 635 1,110 642 1,752 755 997

-66 1,154 921

-83 774 597

-41 1,143 899

-128 1,182 969

-245 1,099 887

-151 1,470 1,231

-150 974 808

-75 944 783

-157 882 788

1.70%

1.64%

1.70%

1.67%

1.62%

1.66%

1.71%

1.71%

1.73%

43.0% 38.5%

38.7% 45.8%

42.4% 37.4%

32.7% 45.6%

40.1% 30.8%

43.8% 39.3%

40.3% 41.8%

38.2% 44.2%

36.6% 43.1%

EPS ($) - Basic

1.06

0.67

1.05

1.57

1.46

1.69

1.98

1.97

1.94

EPS ($) - Diluted

1.06

0.67

1.04

1.55

1.44

1.68

1.97

1.96

1.93

NAV ($)

7.31

6.72

7.18

14.32

13.21

14.14

16.18

14.88

15.90

NAV ($) - Revalued

9.23

8.21

8.75

14.21

13.12

14.04

18.80

17.23

18.57

14.80

9.90

14.90

11.00

10.90

12.30

12.50

13.10

12.40

1.27 0.7% 14.7% 14.7% 17.4%

0.92 0.7% 14.9% 14.9% 16.8%

1.27 0.7% 14.4% 14.4% 15.6%

0.93 0.9% 13.5% 13.5% 15.7%

0.94 1.2% 12.9% 12.9% 15.5%

1.02 1.0% 13.1% 13.1% 15.3%

1.10 1.2% 13.9% 13.9% 17.8%

1.17 1.2% 13.6% 13.6% 17.2%

1.10 1.1% 14.0% 14.0% 17.7%

. 6% 14% 6% 14% 15% 11% 25% 9%

7% 15% 6% 14% 14% 10% 25% 8%

6% 14% 6% 14% 16% 11% 24% 9%

8% 17% 12% 6% 21% 8% 19% 8%

8% 17% 14% 4% 20% 7% 20% 10%

8% 17% 12% 6% 21% 8% 19% 9%

5% 13% 9% 16% 13% 13% 27% 4%

4% 12% 9% 15% 12% 14% 28% 4%

4% 13% 9% 16% 12% 13% 27% 5%

100%

100%

100%

100%

100%

100%

100%

100%

100%

Total Assets Loans Deposits Loans to Deposits

Net Interest Margin (%) Non-interest Income / Total income Cost to income (%)

ROE (%) ROA (%) NPL ratio (%) CET1 (%) Tier 1 Capital (%) Total CAR (%) Loans Breakdown: Tpt, Storage & Comm Building & Construction Manufacturing Non-bank fin institutions Gen commerce Prof & pte individuals Housing loans Others Total Sources: Company & OIR

2

OCBC Investment Research Singapore Equities

Company financial highlights

Income statement Year ended 31 Dec (S$m)

FY12

FY13

FY14F

FY15F

Interest Income Interest Expense Net Interest Income Non-interest Income Fee & Com Income Staff Costs Other Operating Expenses Impairment Pretax profits Net profits

6,202 2,285 3,917 2,578 1,508 -1,597 -1,151 -476 3,351 2,803

6,508 2,388 4,120 2,601 1,731 -1,712 -1,186 -429 3,585 3,009

7,100 2,582 4,518 2,846 1,811 -1,853 -1,461 -587 3,580 3,040

7,406 2,702 4,705 3,074 1,989 -1,992 -1,545 -497 3,877 3,263

FY12

FY13

FY14F

FY15F

5,272 19,810 25,274 203,566 9,689 227,626 33,056 152,930 9,334 252,900

5,333 21,056 26,578 228,253 9,382 257,651 26,881 178,857 9,280 284,229

5,863 22,395 28,569 240,453 9,663 274,930 28,494 194,954 9,605 303,498

5,863 23,957 30,148 253,326 9,953 289,397 29,349 206,651 9,941 319,545

FY12

FY13

FY14F

FY15F

3,748 121 -530 6,933 6,340 -68 -49 5,897 22,396 28,293

3,822 130 -56 -11,117 -11,695 -71 6,293 -5,729 28,293 22,564

4,049 130 -50 1,425 902 102 3,406 4,077 22,564 26,641

4,242 130 -50 1,658 1,065 104 -94 656 26,641 27,297

FY12

FY13

FY14F

0

1.75 14.56 6.5 27.6 60.3 42.3 13.2 1.6 3.0 11.7

1.88 15.36 5.2 0.9 61.3 43.1 12.3 1.5 3.3 11.7

1.90 17.84 9.7 9.4 61.4 45.0 12.1 1.3 3.3 11.1

2.04 18.83 4.1 8.0 60.5 45.5 11.3 1.2 3.3 11.2

Balance sheet As at Dec 31 (S$m) Share capital Revenue & other reserves Shareholders' fund Deposits and other accounts Other liabilities Total liabilities Cash and balances Loans & advances Other assets Total assets

Cash flow statement Year ended 31 Dec (S$m) Pretax profits Depreciation Others Changes in working capital Net cash from operating activities Net cash in investing activities Cash flow from financing activities Change in cash Beg cash Cash at end of year

Year ended 31 Dec (S$m) EPS (S$) NAV per share (S$) Net interest income growth (%) Non-interest income growth (%) Interest Inc / Total Inc (%) Cost-to-income (%) PER (x) Price/NAV (x) Dividend yield (%) ROE (%) Sources: Company, OIR forecasts

Company financial highlights

OCBC Investment Research Singapore Equities

SHAREHOLDING DECLARATION: The analyst/analysts who wrote this report holds/hold NIL shares in the above security.

DISCLAIMER FOR RESEARCH REPORT This report is solely for information and general circulation only and may not be published, circulated, reproduced or distributed in whole or in part to any other person without our written consent. This report should not be construed as an offer or solicitation for the subscription, purchase or sale of the securities mentioned herein. Whilst we have taken all reasonable care to ensure that the information contained in this publication is not untrue or misleading at the time of publication, we cannot guarantee its accuracy or completeness, and you should not act on it without first independently verifying its contents. Any opinion or estimate contained in this report is subject to change without notice. We have not given any consideration to and we have not made any investigation of the investment objectives, financial situation or particular needs of the recipient or any class of persons, and accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of the recipient or any class of persons acting on such information or opinion or estimate. You may wish to seek advice from a financial adviser regarding the suitability of the securities mentioned herein, taking into consideration your investment objectives, financial situation or particular needs, before making a commitment to invest in the securities. OCBC Investment Research Pte Ltd, OCBC Securities Pte Ltd and their respective connected and associated corporations together with their respective directors and officers may have or take positions in the securities mentioned in this report and may also perform or seek to perform broking and other investment or securities related services for the corporations whose securities are mentioned in this report as well as other parties generally.

Privileged / confidential information may be contained in this document. If you are not the addressee indicated in this document (or responsible for delivery of this message to such person), you may not copy or deliver this message to anyone. Opinions, conclusions and other information in this document that do not relate to the official business of OCBC Investment Research Pte Ltd, OCBC Securities Pte Ltd and their respective connected and associated corporations shall not be understood as neither given nor endorsed.

RATINGS AND RECOMMENDATIONS: - OCBC Investment Research’s (OIR) technical comments and recommendations are short-term and trading oriented. - OIR’s fundamental views and ratings (Buy, Hold, Sell) are medium-term calls within a 12-month investment horizon. - As a guide, OIR’s BUY rating indicates a total return in excess of 10% based on the current price; a HOLD rating indicates total returns within +10% and -5%; a SELL rating indicates total returns less than -5%.

Co.Reg.no.: 198301152E

Carmen Lee Head of Research For OCBC Investment Research Pte Ltd

Published by OCBC Investment Research Pte Ltd

Published by OCBC Investment Research Pte Ltd Important disclosures

UOB | BUY

Sep 10, 2014 - Deepening its intra-Asian roots ... the region including further cooperation within the ASEAN Economic ... Asia Pacific Equity Research.

323KB Sizes 5 Downloads 195 Views

Recommend Documents

UOB
3Q15 bottom line beats consensus. In 3Q15, net profit rose 12% q-o-q, to SGD857m, on higher loan-related fees and trading income. Net profit was 6% ahead of consensus, but within our expectations. UOB declared a one-off SGD0.20 special DPS to commemo

UOB Ltd - InvestingNote
Oct 31, 2014 - 30. 18.00. 19.00. 20.00. 21.00. 22.00. 23.00. 24.00. 25.00. O ct-1. 3. Ja n-1. 4. A p r-14. Ju l-14. Volume, mn. UOB SP EQUITY. STI rebased. 0% 50% 100% .... Table 5. Loans by currencies. $m. 3Q14. 3Q13. %y-y ch. 2Q14 %q-q ch. Singapor

United Overseas Bank (UOB SP)
Oct 30, 2015 - Management indicated that it was comfortable with the credit quality of the portfolio and the ... While management characterises the short-term loan-growth outlook as ..... Ltd. may currently provide or may intend to provide investment

United Overseas Bank (UOB SP)
7 Jan 2015 - No unit has been auctioned off. As we suggested in our 5 Jan sector note,. “Xenophobia” unwarranted, UOB should be the most exposed to. Sentosa. ...... Stockbroking Business: Level 8, Tower C, Dataran Maybank,. No.1, Jalan Maarof. 59

UOB 2015 026 Burofax.cas.pdf
Towers Watson (actuarios internos)– para que se envíen de manera. inmediata las certificaciones de APORTACIONES y DERECHOS. CONSOLIDADOS ...

Buy
Jul 4, 2016 - กลับเข้าสู่วงจรการเติบโตอีกครั้ง. Market Cap: USD3,032m. Bloomberg Ticker: LH TB. เราปรับค าแนะน า LH ขึ้นเป็น “ซื้อ״

T-Buy
Dec 18, 2017 - ปี 2560 HMPRO เปิดสาขาได้ตามเป้าหมายเป็น HMPRO 2 สาขา, MEGA HOME 1 สาขา และ สาขาที่. มาเลเซีย 4 สาขา ปัจจุบ

ENG - UoB Estimated Program Cost, Fall 2017.pdf
ENG - UoB Estimated Program Cost, Fall 2017.pdf. ENG - UoB Estimated Program Cost, Fall 2017.pdf. Open. Extract. Open with. Sign In. Main menu.

UOB 2015 029 PSC (1)_web.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. UOB 2015 029 ...

UOB 2015 027 BMN, tic-tac, tic-tac.cas.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. UOB 2015 027 BMN, tic-tac, tic-tac.cas.pdf. UOB 2015 027 BMN, tic-tac, tic-tac.cas.pdf. Open. Extract. Open

T-Buy
Nov 15, 2017 - บำท ถึง 25% ทั้งนี้เรำปรับใช้รำคำพื้นฐำน QH เป็น ณ สิ้นปี 2561 ที่ 3.24 บำท อิงวิธี SOTP. ประกอบด้วà¸

UOB 2015 029 PSC (1)_web.cas.pdf
There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. UOB 2015 029 ...

T-Buy
Nov 14, 2017 - Prachuabkirikhan 77110. Tel. 0-3252-3270. THA PHRA. 99 The Mall Thapra Mall Building,. 9th Floor, Ratchadapisek Road, Bukkalo, Thonburi,.

T-Buy
Nov 15, 2017 - 3เหตุผลที่คงค ำแนะน ำ “ซื้อเก็งกำไร” หลังกำรประชุมนักวิเครำะห์ 1) แม้กำไรปกติ 3Q60. ชะลอต

ENG - UoB Estimated Program Cost, Spring 2018.pdf
ENG - UoB Estimated Program Cost, Spring 2018.pdf. ENG - UoB Estimated Program Cost, Spring 2018.pdf. Open. Extract. Open with. Sign In. Main menu.

ROBINS - T-Buy
Dec 29, 2017 - 3เหตุผลที่เราแนะน า “เก็งก าไร” 1) สาขาใหม่ในรูปแบบ “Hello Beauty” เริ่มที่สาขามหาชัย. ได้รับผà

JWD - Buy - Settrade
Apr 19, 2018 - คาดก าไรปกติ 1Q61 ยังแข็งแกร่ง ได้ประโยชน์จาก EEC. เราคาดรายได้ 1Q61 ที่640 ล้านบาท (+1.3% QoQ, +11.9% YoY) น าà¹

JWD - Buy - Settrade
May 4, 2018 - Tel. 0 2120 3700 Fax. 0 2541 1505. Mahachai. 67/518 Moo 4, Ekachai Road,. Khokham, Muang, Samutsakhon 74000. Tel. 0 3411 9719 Fax.

Buy Back.pdf
Hello, and welcome to the WPI Pep Band! On behalf of the ... interesting in joining the band! ... us proof of purchase and you are good to go! ... Please fill out and turn in a copy to the Vice President, Matthew Bisson. ... Displaying Buy Back.pdf.

Buy Lyrica
cheap sunglasses lyrica buy lyrica 75 mg buy lyrica online australia buy lyrica 25mg. Buy lyrica online usa, buy lyrica online uk, buy lyrica 150 mg buy lyrica 150 ...

buy-proposal-essay.pdf
heat it. . Page 1 of 1. buy-proposal-essay.pdf. buy-proposal-essay.pdf. Open. Extract. Open with. Sign In. Details. Comments. General Info. Type. Dimensions.

We Buy Houses.pdf
Page 1 of 5. http://www.finallysold.com/local-home-buyers/AZ/Phoenix.html. Are​ ​you​ ​looking​ ​to​ ​sell​ ​your​ ​AZ​ ​home​ ​quickly​ ​and​ ​still​ ​get​ ​top. dollar​ ​for​ ​it?​ ​Thenâ€